Pharmaceutical

GE HealthCare announces cash dividend for third quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per…

4 months ago

Nanocoatings Market Surges to USD 20.4 Billion by 2030, Propelled by 6.9% CAGR – Verified Market Reports®

The Nanocoatings market is driven by increasing demand across industries like automotive, electronics, and healthcare, where the coatings' enhanced durability,…

4 months ago

Live Cell Imaging Market Surges to USD 4.42 Billion by 2030, Propelled by 7.52% CAGR – Verified Market Reports®

The live cell imaging market is driven by advancements in cell biology research, increasing demand for high-content screening, and the…

4 months ago

OM1 Earns Frost & Sullivan’s 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms

OM1's innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI…

4 months ago

Deerfield Group Bolsters Marketing, Communications Leadership With New Senior Appointments

Strengthens Deerfield's award-winning marketing and communications leadership to deliver specialized solutions to clients at all stages of development and commercialization…

4 months ago

Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and…

4 months ago

Ovia Health Expands Women’s Health Offerings with Comprehensive Postpartum Experience

New solution is the first holistic program available in a digital app to help women manage the postpartum period BOSTON,…

4 months ago

Procaps Issues Shareholder Letter Update

MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a…

4 months ago

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to select a higher starting dose…

4 months ago